Morgan L. Maeder

17.3k citations

41 papers · 11.4k indexed · 6 hit papers · h-index 27

Molecular Biology top 0.2%
Genetics top 0.5%
Plant Science top 2%
Business and International Management top 0.1%
Cell Biology top 1%

Co-authors: J. Keith Joung Yanfang Fu Jeffry D. Sander Deepak Reyon Cyd Khayter Randall T. Peterson Jing-Ruey Joanna Yeh Shengdar Q. Tsai
Topics: CRISPR and Genetic Engineering (31 papers)Advanced biosensing and bioanalysis techniques (16 papers)RNA Interference and Gene Delivery (13 papers)
Cited by: Business and International Management Aging Molecular Biology
Journals: Nature Proceedings of the National Academy of Sciences Nucleic Acids Research
Partner nations: United States Germany France

In The Last Decade

Morgan L. Maeder

41 papers receiving 11.1k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells

2013 2.5k citations Yanfang Fu, Cyd Khayter et al. Nature Biotechnology profile →
Efficient genome editing in zebrafish using a CRISPR-Cas system

2013 2.2k citations Woong Y. Hwang, Yanfang Fu et al. Nature Biotechnology profile →
Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in vitro and in vivo

2014 1.2k citations John A. Zuris, David B. Thompson et al. Nature Biotechnology profile →
CRISPR RNA–guided activation of endogenous human genes

2013 926 citations Morgan L. Maeder, Samantha J Linder et al. Nature Methods profile →
High-frequency modification of plant genes using engineered zinc-finger nucleases

2009 500 citations Fengli Fu, Morgan L. Maeder et al. profile →
Genome-editing Technologies for Gene and Cell Therapy

2016 472 citations Morgan L. Maeder, Charles A. Gersbach Molecular Therapy profile →

Peers

Countries citing papers authored by Morgan L. Maeder

Since Specialization

Citations

This map shows the geographic impact of Morgan L. Maeder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Morgan L. Maeder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Morgan L. Maeder more than expected).

Fields of papers citing papers by Morgan L. Maeder

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Morgan L. Maeder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Morgan L. Maeder. The network helps show where Morgan L. Maeder may publish in the future.

Co-authorship network of co-authors of Morgan L. Maeder

This figure shows the co-authorship network connecting the top 25 collaborators of Morgan L. Maeder. A scholar is included among the top collaborators of Morgan L. Maeder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Morgan L. Maeder. Morgan L. Maeder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	An epigenetic editor targeting human PCSK9 efficiently and durably lowers Low Density Lipoprotein Cholesterol (LDL-C) in non-human primates 2024 ·European Heart Journal ·Francine Tremblay,Kevin R. Kelly,Svati H. Shah,(unknown),C.-W. Ko,Stuart G. Clarkson,Ricardo N. Ramírez,Erica M. Hildebrand,Sarah Wright,(unknown),(unknown),Sahar Abubucker,Ari E. Friedland,Morgan L. Maeder,Jie Xiong	2
2	Efficient in vivo editing of CEP290 IVS26 by EDIT-101 as a novel therapeutic for treatment of Leber Congenital Amaurosis 10 2018 ·Investigative Ophthalmology & Visual Science ·Michael Stefanidakis,Morgan L. Maeder,George S. Bounoutas,(unknown),(unknown),Scott Haskett,(unknown),Steven J. Samuelsson,Georgia Giannoukos,Dawn Ciulla,Eugenio Marco,Christopher J. Wilson,Peter Baciu,(unknown),(unknown),Haiyan Jiang	2
3	UDiTaS™, a genome editing detection method for indels and genome rearrangements 2018 ·BMC Genomics ·Georgia Giannoukos,Dawn Ciulla,Eugenio Marco,(unknown),Luis Barrera,Anne Bothmer,(unknown),Sebastian Gloskowski,Hariharan Jayaram,Morgan L. Maeder,Maxwell N. Skor,Tongyao Wang,Vic E. Myer,Christopher J. Wilson	93
4	Somatic Gene Editing of GUCY2D by AAV-CRISPR/Cas9 Alters Retinal Structure and Function in Mouse and Macaque 2018 ·Human Gene Therapy ·(unknown),(unknown),(unknown),Diego Fajardo,(unknown),Jim Peterson,Christianne E. Strang,Dibyendu Chakraborty,Sebastian Gloskowski,Scott Haskett,Steven J. Samuelsson,Haiyan Jiang,C. Douglas Witherspoon,Paul D. Gamlin,Morgan L. Maeder,Sanford L. Boye	66
5	Genome-editing Technologies for Gene and Cell Therapybreakdown → 2016 ·Molecular Therapy ·Morgan L. Maeder,Charles A. Gersbach	472
6	Characterization of Staphylococcus aureus Cas9: a smaller Cas9 for all-in-one adeno-associated virus delivery and paired nickase applications 2015 ·Genome biology ·Ari E. Friedland,(unknown),Pankhuri Singhal,(unknown),Shen Shen,Minerva E. Sanchez,Eugenio Marco,Gregory Gotta,Morgan L. Maeder,Edward M. Kennedy,Anand Kornepati,Alexander A. Sousa,McKensie Collins,Hari Jayaram,Bryan R. Cullen,David Bumcrot	223
7	Rescue of DNA-PK Signaling and T-Cell Differentiation by Targeted Genome Editing in a prkdc Deficient iPSC Disease Model 2015 ·PLoS Genetics ·(unknown),Johannes Kuehle,Christian Reimann,(unknown),Jamal Alzubi,Morgan L. Maeder,Heimo Riedel,(unknown),Tobias Cantz,Cornelia Rudolph,Claudio Mussolino,J. Keith Joung,Axel Schambach,Toni Cathomen	9
8	Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in vitro and in vivobreakdown → 2014 ·Nature Biotechnology ·John A. Zuris,David B. Thompson,Yilai Shu,John P. Guilinger,(unknown),Johnny H. Hu,Morgan L. Maeder,J. Keith Joung,Zheng‐Yi Chen,David R. Liu	1160
9	Heritable and Precise Zebrafish Genome Editing Using a CRISPR-Cas System 2013 ·PLoS ONE ·Woong Y. Hwang,Yanfang Fu,Deepak Reyon,Morgan L. Maeder,(unknown),Jeffry D. Sander,J. Keith Joung,Randall T. Peterson,Jing-Ruey Joanna Yeh	278
10	High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cellsbreakdown → 2013 ·Nature Biotechnology ·Yanfang Fu,(unknown),Cyd Khayter,Morgan L. Maeder,Deepak Reyon,J. Keith Joung,Jeffry D. Sander	2476
11	CRISPR RNA–guided activation of endogenous human genesbreakdown → 2013 ·Nature Methods ·Morgan L. Maeder,Samantha J Linder,Vincent Cascio,Yanfang Fu,Quan Ho,J. Keith Joung	926
12	Robust, synergistic regulation of human gene expression using TALE activators 2013 ·Nature Methods ·Morgan L. Maeder,Samantha J Linder,Deepak Reyon,(unknown),Yanfang Fu,Jeffry D. Sander,J. Keith Joung	139
13	Evaluation of OPEN Zinc Finger Nucleases for Direct Gene Targeting of the ROSA26 Locus in Mouse Embryos 2012 ·PLoS ONE ·Mario Hermann,Morgan L. Maeder,(unknown),(unknown),Burkhard Becher,Kurt Bürki,Cyd Khayter,Adriano Aguzzi,J. Keith Joung,Thorsten Buch,Paweł Pelczar	33
14	Induction of Stable Drug Resistance in Human Breast Cancer Cells Using a Combinatorial Zinc Finger Transcription Factor Library 2011 ·PLoS ONE ·J. Lee,(unknown),Ben S. Wittner,Morgan L. Maeder,(unknown),Magdalena Lang,Sailajah Janarthanan,Ultan McDermott,Vijay Yajnik,Sridhar Ramaswamy,J. Keith Joung,Dennis C. Sgroi	11
15	Zinc-Finger Nucleases for Somatic Gene Therapy: The Next Frontier 2011 ·Human Gene Therapy ·(unknown),Morgan L. Maeder,J. Keith Joung,Toni Cathomen	57
16	ZiFiT (Zinc Finger Targeter): an updated zinc finger engineering tool 2010 ·Nucleic Acids Research ·Jeffry D. Sander,Morgan L. Maeder,Deepak Reyon,Daniel F. Voytas,J. Keith Joung,Drena Dobbs	269
17	Engineering Single Cys2His2 Zinc Finger Domains Using a Bacterial Cell-Based Two-Hybrid Selection System 2010 ·Methods in molecular biology ·Stacey Thibodeau-Beganny,Morgan L. Maeder,J. Keith Joung	8
18	Predicting success of oligomerized pool engineering (OPEN) for zinc finger target site sequences 2010 ·BMC Bioinformatics ·Jeffry D. Sander,Deepak Reyon,Morgan L. Maeder,Jonathan E. Foley,Stacey Thibodeau-Beganny,Xiaohong Li,Maureen Regan,(unknown),(unknown),Fengli Fu,Daniel F. Voytas,J. Keith Joung,Drena Dobbs	17
19	Targeted mutagenesis in zebrafish using customized zinc-finger nucleases 2009 ·Nature Protocols ·Jonathan E. Foley,Morgan L. Maeder,Joseph Pearlberg,J. Keith Joung,Randall T. Peterson,Jing-Ruey Joanna Yeh	106
20	Rapid Mutation of Endogenous Zebrafish Genes Using Zinc Finger Nucleases Made by Oligomerized Pool ENgineering (OPEN) 2009 ·PLoS ONE ·Jonathan E. Foley,Jing-Ruey Joanna Yeh,Morgan L. Maeder,Deepak Reyon,Jeffry D. Sander,Randall T. Peterson,J. Keith Joung	193

About Morgan L. Maeder

Morgan L. Maeder is a scholar working on Molecular Biology, Genetics and Sensory Systems, having authored 41 papers that have together received 11.4k indexed citations. Recurring topics across this work include CRISPR and Genetic Engineering (31 papers), Advanced biosensing and bioanalysis techniques (16 papers) and RNA Interference and Gene Delivery (13 papers). The work is most often cited by research in Business and International Management (866 citations), Aging (681 citations) and Molecular Biology (10.3k citations). Morgan L. Maeder has collaborated with scholars based in United States, Germany and France. Frequent co-authors include J. Keith Joung, Yanfang Fu, Jeffry D. Sander, Deepak Reyon, Cyd Khayter, Randall T. Peterson, Jing-Ruey Joanna Yeh, Shengdar Q. Tsai, Woong Y. Hwang and Charles A. Gersbach. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact